The higher percentage of P2X7 receptor in septic lymphocytes and its potential relationship with lymphocyte activity in sepsis open the possibility of P2X7-blocking therapies as a potential treatment for sepsis to improve lymphocyte survival. The gene discussed is P2RX7; the disease is Sepsis.